FDA Approves Wegovy (Semaglutide) for Obesity in Teens 12 and Up ...Middle East

Medscape - News
FDA approves semaglutide 2.4mg (Wegovy), a once-weekly subcutaneous injection, for treating obesity in adolescents aged 12 years and older. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Wegovy (Semaglutide) for Obesity in Teens 12 and Up )

Apple Storegoogle play

Also on site :

Most viewed in News


Latest News